Drug Approval | January 16, 2023
Granules India’s Gagillapur facility completes USFDA inspection
The company will respond to these observations within the stipulated time period.
The company will respond to these observations within the stipulated time period.
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
Seeks partnership between government and private medical colleges for providing superior medical education
The Government of India is supporting the states in active case detection, surveillance, treatment, supply of diagnostic kits, medicines, sprays etc.
The unit will have installed manufacturing capacity of over 15 million vials annually that includes lyophilized vials, all in the anti-cancer segment
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
Upon approval, XPHOZAH would be the first and only phosphate absorption inhibitor, offering patients a novel mechanism
Centre and states need to work in tandem and in a collaborative spirit as was done during the previous surges for COVID-19 prevention and management
Surana is a chartered accountant with an all-India rank.
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
Subscribe To Our Newsletter & Stay Updated
